Mark R. Denison - Concepedia

Author

Mark R. Denison

Vanderbilt University Medical Center ORCID

Also Known As

Alan Whitmore, Alicia T. Widge, Bam, Radha, Baric, R. S., Baric, Ralph S., Bluemling, Gregory R., Brown, Ariane J., Cherry, Sara, Clarke, Michael O., Davis, Nancy

202

Publications

29.2K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Medical Center University of North Carolina at Chapel Hill Vanderbilt University Bipar National Institute of Allergy and Infectious Diseases

About

Mark R. Denison is an author at Vanderbilt University Medical Center specializing in virology, medicine, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	47	7.1K
2	Natural Sciences	18	19	3K
3	Biochemistry	7	7	430
4	Engineering	1	1	138
5	Public Health	1	1	111

Mark R. Denison

111

Publications

26.6K

Citations

H-Index

Page 1

	Year	Citations
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael, New England Journal of Medicine	2020	3.4K
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV Timothy P. Sheahan, Amy Sims, Sarah R. Leist, Nature Communications	2020	1.8K
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses Timothy P. Sheahan, Amy Sims, Rachel L. Graham, Science Translational Medicine	2017	1.6K
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist, Nature VaccinationPrototype Pathogen PreparednessVaccine DevelopmentImmunologyVirology	2020	1.6K
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults Evan J. Anderson, Nadine Rouphael, Alicia T. Widge, New England Journal of Medicine	2020	1.6K
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease Maria L. Agostini, Erica L. Andres, Amy Sims, mBio	2018	1.5K
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen Jesper Pallesen, Nianshuang Wang, Kizzmekia S. Corbett, Proceedings of the National Academy of Sciences ImmunologyViral PathogenesisImmunodominanceMolecular BiologyOptimal Prefusion Conformation	2017	1.2K
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice Timothy P. Sheahan, Amy Sims, Shuntai Zhou, Science Translational Medicine	2020	1.1K
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus I‐Chueh Huang, Charles C. Bailey, Jessica L. Weyer, PLoS Pathogens	2011	618
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer, Cell Reports	2020	530

Page 1